Skip to main content

Articles

Conference Highlights ASH

Favorable Data for Ruxolitinib and for a New JAK Inhibitor in Myelofibrosis

Multiple Myeloma, Multiple Myeloma, Oncology

Next-Generation Proteasome Inhibitors Cause Less Peripheral Neuropathy

Conference Highlights ASH

Genetic Profiles Linked to Hematologic Outcomes

Multiple Myeloma, Multiple Myeloma, Oncology

Future Directions in Myeloma

Conference Highlights ASH

DVT Prophylaxis: First Comparison of Catheter- Directed Thrombolysis versus Standard Care

Leukemia, Oncology

Ponatinib Overcomes Hard-to-Treat T315I Mutation in Patients with CML/ALL

Practice Management

Primary Care Shortages: Strengthening This Sector Is Urgently Needed, Now and in Preparation for Healthcare Reform

Stakeholder Perspective

Primary Care Shortages: It Is All About the Money After All

The Business Case for Ending Homelessness: Having a Home Improves Health, Reduces Healthcare Utilization and Costs

American Health & Drug Benefits: Reflections on the First 5 Years

Original Research

Daily Average Consumption of 2 Long-Acting Opioids: An Interrupted Time Series Analysis

Stakeholder Perspective

Daily Average Consumption of 2 Long-Acting Opioids and Coverage Decisions

Page 209 of 244
Results 2081 - 2090 of 2436